top of page
welcome to nina
we are a specialized venture capital firm investing exclusively at the intersection of healthcare and technology

health
technology
specialized

🧡 data, compute
& need-driven
founders

pan-European plus
United States, Israel,
Canada, Australia

pre-seed to seed+
focus for new
investments

ticket sizes
from 200k €
to 1500k €

can lead
rounds, and
coinvest
( what we don't do: drugs and vaccines )
pages
nina by the numbers
1
office
in Europe,
home to a team of
12 nationalities
3
funds
currently under
management
since 2019
8
core
full-time,
permanent
team members
18
countries
where our companies
in portfolio were originally founded
51
companies
newly invested
across our
managed funds
100
%
committed
to healthcare &
need-driven
founders
bottom of page